Cargando…

Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma

INTRODUCTION: The objective of this study was to evaluate real-world effectiveness of latanoprostene bunod (LBN) ophthalmic solution 0.024% in treatment-naïve patients newly diagnosed with open-angle glaucoma (OAG) or ocular hypertension. METHODS: This multicenter retrospective chart review included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okeke, Constance O., Burstein, Eitan S., Trubnik, Valerie, Deom, James E., Cooper, Michael S., Brinkley, Desirae A., Thimons, J. James, Kabiri, Alexander J., Gelb, Kerry M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708554/ https://www.ncbi.nlm.nih.gov/pubmed/33034885 http://dx.doi.org/10.1007/s40123-020-00307-0

Ejemplares similares

Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
por: Hoy, Sheridan M.
Publicado: (2018)

Latanoprostene Bunod 0.024% in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Meta-Analysis
por: Lo, Tzu-Chen, et al.
Publicado: (2022)

Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
por: Hoy, Sheridan M.
Publicado: (2018)

Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
por: Addis, Victoria M, et al.
Publicado: (2018)

Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension
por: Fingeret, Murray, et al.
Publicado: (2019)

Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects
por: Araie, Makoto, et al.
Publicado: (2015)

Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
por: Kawase, Kazuhide, et al.
Publicado: (2016)

Critical evaluation of latanoprostene bunod in the treatment of glaucoma
por: Garcia, Giancarlo A, et al.
Publicado: (2016)

Use of Latanoprostene Bunod as Adjunctive Glaucoma Therapy in Refractory Glaucoma
por: Zhou, Benjamin, et al.
Publicado: (2022)

The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
por: Cavet, Megan E., et al.
Publicado: (2018)

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
por: Weinreb, Robert N, et al.
Publicado: (2015)

Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
por: Wang, Yulong, et al.
Publicado: (2020)

Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
por: Harasymowycz, Paul, et al.
Publicado: (2022)

EHMTI-0024. The typical duration of migraine aura: a prospective diary-based study
por: Viana, M, et al.
Publicado: (2014)

Letrozole in the neoadjuvant setting: the P024 trial
por: Ellis, Matthew J., et al.
Publicado: (2007)

Letrozole in the neoadjuvant setting the P024 trial
por: Ellis, Matthew J., et al.
Publicado: (2007)

CMS ARDA Meeting, ARDA-Note-2004-024
por: CERN. Geneva
Publicado: (2004)

P03-024 – Early onset IBD treated by tocilizumab
por: Helbling, R, et al.
Publicado: (2013)

Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
por: Ellis, Matthew J., et al.
Publicado: (2008)

Status Report on the NA60 Pixel Detector Project - 2002-024
por: Lourenço, Carlos, et al.
Publicado: (2002)

PW02-024 - A case of candle syndrome treated with thalidomide
por: Yamazaki, K, et al.
Publicado: (2013)

P024. Features of headache attributed to carotid and vertebral arteries dissection
por: Marsili, Luca, et al.
Publicado: (2015)

PW01-024 – Phenotypic analysis of a MEFV negative FMF cohort
por: Soriano, A, et al.
Publicado: (2013)

PW03-024 - A transgenic mouse model for variant procaspase-1
por: Hermsdorf, A, et al.
Publicado: (2013)

PW02-024-B - First report of AA amyloidosis in Blau syndrome
por: Ruiz-Ortiz, E, et al.
Publicado: (2013)

P01-024 – Vascular risk assessment and MMP-3 gene in FMF
por: Mir, S, et al.
Publicado: (2013)

AB024. Interpretation for Y chromosomal microdeletions of EAA/EMQN 2013 guideline
por: Li, Zheng
Publicado: (2016)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

ESMO20 YO for YO: highlights on metastatic NSCLC-Keynote 024 update
por: Mariamidze, E., et al.
Publicado: (2021)

P024 Children’s sleep and fathers’ health and wellbeing: a systematic review
por: Coles, L, et al.
Publicado: (2021)

O024 Modifying light environments according to individual circadian light sensitivity
por: Stone, J, et al.
Publicado: (2022)

P024 Defining sleep hygiene: A scoping review of intervention studies
por: El Kazzi, M, et al.
Publicado: (2022)

UCG Report on the ALICE Inner Tracking Upgrade TDR (CERN-LHCC-2013-024)
por: Barker, G, et al.
Publicado: (2014)

AB024. The penile dermal flap* for defect reconstruction in Peyronie’s disease (PD) deformities
por: Krishnamurti, Sudhakar
Publicado: (2015)

Specific clinical and immune features of CD68 in glioma via 1,024 samples
por: Wang, Le, et al.
Publicado: (2018)

MON-LB024 Episodic Hypoglycemia in Non-Diabetics: Differentiating Distressing from Deadly
por: Windham, Mary, et al.
Publicado: (2019)

MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
por: folawewo, kehinde Matilda, et al.
Publicado: (2020)

AB024. A case of bullous systemic lupus erythematosus confined to the oral mucosa
por: Strunck, Jennifer, et al.
Publicado: (2021)

P024 Genetic determinants of antifungal drug resistance in Fusarium solani species complex
por: Trivedi, Pinal, et al.
Publicado: (2022)

PSAT024 A Case of Mild Autonomous Cortisol Secretion Managed with Active Surveillance
por: Thakkar, Aditi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0vgccd6sibqpl2qvl3b7ic0l9h